Biological Information
Background Information:
Phosphodiesterase 4D2 (PDE4D2), a cAMP-specific phosphodiesterase, is located in both central nervous system and peripheral tissues. The high affinity of Zn2+ for PDE4D suggests that it may play a role in the regulation of its activity. Inhibition of central cAMP-specific PDE4D2 may be useful in the treatment of chronic depression but may also be associated with emesis. Inhibition of peripheral PDE4D2 may be useful in the treatment of a number of disorders including asthma, chronic obstructive pulmonary disease and inflammation as well as antineoplastic functions.
Family:
PDE
Sub Family:
Phosphodiesterase
Class:
Cyclic Nucleotide Signaling
Protein Name:
PDE4D
Uniprot Number:
Q08499
Protein Aliases:
phosphodiesterase E3 dunce homolog (Drosophila)
Gene Name:
PDE4D
Gene ID:
5144
Accession Number:
NM_001197221
Organism:
Human
Construct Details:
Fragment (2-end), Recombinant
Assay Information
Assay Type:
Biochemical
Assay Sub Type:
Enzymatic
Functional Mode:
Antagonist
Detection Method:
Fluorescence Polarization
Measured Response:
Fluorescence
Testing Information
Procedure Summary:
Human recombinant PDE4D2 expressed in insect Sf9 cells are used. Test compound and/or vehicle is preincubated with 5 ng/ml enzyme‡ in Tris-HCl buffer pH 7.2 for 15 minutes at 25⁰C. The reaction is initiated by addition of 100 nM fluorescein lableled cAMP for another 15 minutes incubation period and terminated by addition of IMAP binding solution. IMAP complexes with phosphate groups on nucleotide monophosphate generated from cyclic nucleotides through PDE activity. Determination of the amount of complex formed is read spectrofluorimetrically at 470 nm/525 nm. Compounds are screened at 10 µM.
Substrate:
0.1 µM FAM-cAMP
Incubation:
15 min at 25°C
Control Inhibitor:
Rolipram
Criteria For Significance:
≥ 50% of max stimulation or inhibition
Test Concentration / Dose:
Suggested concentration for initial testing is 10 uM
Test Sample Requirements:
Minimum for 1) Screen: 25 μl of 10 mM stock -OR- 1 mg (pre-weighed). 2) Dose Response: 60 μl of 10 mM stock -OR- 1 mg (pre-weighed).
Minimum Order Quantity:
2
Turnaround Time
Standard:
10 Business Days
Reference Compound Data
Clinical Relevance
Therapeutic Area:
Inflammation/Allergy
Additional Information
Brand:
LeadHunter
Testing Location:
Taiwan - Taipei
RELATED SOLUTIONS